Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04283669 |
|---|---|
| Brief Title: | Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas (NF110) |
| First Submitted : | February 22, 2020 |
| First Submitted that Met QC Criteria : | February 22, 2020 |
| First Posted : | February 25, 2020 |
| Last Update Submitted that Met QC Criteria : | September 8, 2023 |
| Last Update Posted : | September 11, 2023 |